Dextromethorphan and guaifenesin use really should be monitored very carefully in people with "poor metabolizer" CYP2D6 enzyme amounts and individuals who will be sedated. This combination medication provides a massive median poisonous dose (TD50) to median helpful dose (ED50) ratio (or therapeutic index) in these sufferers. 资助维基百科 外观 创建账号 登录 https://spidermonkeybuyuk67788.izrablog.com/30688716/not-known-factual-statements-about-dextromethorphan-dxm-for-sale-near-me